Company: RNST
Filing Date: 2025-03-12
Form Type: DEF 14A
Source: 0000715072-25-000085
Chunk: 46

Company: RENASANT CORP
Filing Date: 2025-03-12
Form: DEF 14A
Chunk 46
---
: 60.4%

Total Performance-based Compensation Total Performance-based Compensation

(Short and Long-Term): 50.7% (Short and Long-Term): 36.9%

n Fixed - Base Salary n Variable - Time-based Equity

n Variable - Performance-based Cash n Variable - Performance-based Equity

The percentage of total performance-based compensation for our NEOs other than our CEO is lower than the percentage for the CEO, primarily due to the structure of Mr. McGraw’s 2024 compensation. Mr. McGraw did not receive a performance-based equity award in 2024, and the final amount of his annual cash incentive for 2024 was prorated as if he had retired on May 1, 2024 (the same proration was applied to his time-based restricted stock award). Excluding Mr. McGraw’s compensation, performance-based compensation for our NEOs other than our CEO was 45.5% of their total compensation for 2024. More detailed information about the nature and amount of compensation we paid to our NEOs and payouts for performance-based compensation is provided below under the heading “2024 Compensation Decisions.”

#### Say-on-Pay and Shareholder Engagement
When setting compensation policy and structuring the compensation of our NEOs and other senior executives, the compensation committee solicits and values the viewpoints of shareholders and other stakeholders. At our 2024 annual meeting, our say-on-pay vote received 96.7% support from our shareholders. The compensation committee considers this vote to be an endorsement of our compensation program, including our balance between cash and equity and between performance-based and fixed compensation.

In late 2023 and early 2024, Albert J. Dale, III, the chair of the board’s compensation committee, as well as representatives of executive management and our investor relations team met with some of our top institutional and other large shareholders (representing approximately 29% of our then-outstanding shares) to solicit their views on our compensation program, among other practices. For a discussion of the feedback we received related to our executive compensation program, please see the Compensation Discussion & Analysis section of the proxy statement for our 2024 annual meeting. Our 2024 executive compensation program and this CD&A remain responsive to this feedback.

As discussed in more detail below in the Proposals section under the heading “Proposal 4 - Advisory Vote on Executive Compensation,” we are asking shareholders to adopt, in a non-binding advisory vote, a resolution approving the compensation paid to our named executives in